Ashland Specialty Ingredients is expanding its R&D facilities internationally to help measure and support the performance of its personal-care ingredients portfolio.
“Ingredients and formulation architecture can be further evaluated based on actual climate, geography and environmental conditions," explained Linda Foltis, vice president of care specialties research and development, Ashland Specialty Ingredients. "At the same time, Ashland can evaluate how ingredients, incorporated into prototype formulations, are most likely to be used by consumers in real-world conditions. This comprehensive evaluation syst
“Ingredients and formulation architecture can be further evaluated based on actual climate, geography and environmental conditions," explained Linda Foltis, vice president of care specialties research and development, Ashland Specialty Ingredients. "At the same time, Ashland can evaluate how ingredients, incorporated into prototype formulations, are most likely to be used by consumers in real-world conditions. This comprehensive evaluation system allows us to gain insights into the way consumers experience our ingredients and formulation architecture.”
Taking into account out-of-the laboratory variables, such as environmental effects, Ashland now offers a complete picture of clinical studies’ performances and values of its ingredient portfolio in virtually any market around the world. The consumer panel and clinical studies conducted will be included in major markets such as:
- Shanghai, China;
- Mumbai, India;
- The Netherlands and
- The United States.
For more information, visit the Cosmetics & Toiletries website.
